Skip to main content

Strongyloidiasis: Epidemiology, clinical manifestations and new methods for diagnosis and treatment

Conclusion

Strongyloidosis is a parasitic disease of the intestines, seen mainly in tropical areas. It is quite likely that, because its manifestations are milder than those of other tropical diseases, it may be overlooked in regions where parasitic diseases such as hookworms and roundworms are endemic. With future improvements in hygiene and the resulting decreases in parasitic diseases, increasing attention will be focused on strongyloidiasis in tropical regions — a phenomenon currently being observed in Okinawa.

Studies on the diagnosis and treatment of apparently healthy Strongyloides carriers have only just started. These studies can be expected to play a major role in improving the near-future health and welfare of people in tropical regions of the world. Parasitic diseases in Japan have a strong local character; a long-term eradication program, with due consideration to HTLV-1 infection, must be instituted.

References

  1. 1.

    Grove DI. Strongyloidiasis, a major roundworm infection of man. New York: Taylor & Francis, 1989.

    Google Scholar 

  2. 2.

    Gillim SE, Gottlieb LS. The digestive system and liver. In: Harawi SJ, O'Hara CJ (eds) Pathology and pathophysiology of AIDS and HIV-related diseases. London: Chapman & Hall Medical, 1989:327.

    Google Scholar 

  3. 3.

    Shikiya K, Saito A. Strongyloidiasis. Clin Microbiol 1993;6:1011–1015 (in Japanese).

    Google Scholar 

  4. 4.

    Smallman LA, Young JA, Shortland-Webb WR, Carey MP, Michael J.Strongyloides stercoralis hyperinfestation syndrome withEscherichia coli meningitis: report of two cases. J Clin Pathol 1986;39:366–370.

    CAS  PubMed  Google Scholar 

  5. 5.

    Boram LH, Keller KF, Justus DE, Collins JP. Strongyloidiasis in immunocompromised patients. Am J Clin Pathol 1981; 76:778–781.

    CAS  PubMed  Google Scholar 

  6. 6.

    Furuya N, Shimozi K, Nakamura H, Owan C, Tateyama M, Saito A, et al. A case report of meningitis and sepsis due toEnterococcus faecium complicated with strongyloidiasis. Jpn J Infect Dis 1989;63:1344–1349 (Engl abst).

    CAS  Google Scholar 

  7. 7.

    Saito A. Strongyloidiasis — recent problems. Mod Med 1989;35:428–433.

    Google Scholar 

  8. 8.

    Nakada K, Yamaguchi K, Furugen S, Nakasone T, Nakasone K, Oshiro Y, et al. Monoclonal integration of HTLV-1 proviral DNA in patients with strongyloidiasis. Int J Cancer 1987;40:145–148.

    CAS  PubMed  Google Scholar 

  9. 9.

    Petithory JC, Derouin F. AIDS and strongyloidiasis in Africa. Lancet 1987;i:921.

    Google Scholar 

  10. 10.

    Zygmunt DJ.Strongyloides stercoralis. Infect Control Hosp Epidemiol 1990;11:495–497.

    CAS  PubMed  Google Scholar 

  11. 11.

    Koga K, Kasuya S, Khamboonruang C, Sukhavat K, Ieda M, Takatsuka N, et al. A modified agar plate method for detection ofStrongyloides stercolaris. Am Soc Trop Med Hyg 1991;518–521

  12. 12.

    Asato R, Nakasone T, Yoshida C, Arakaki T, Ikeshiro T, Murakami H. A new method to detectStrongyloides stercolaris from human stool. Jpn J Trop Med Hyg 1988;16:16–21.

    Google Scholar 

  13. 13.

    Asato R, Nakasone T, Yoshida C, Arakaki T, Ikeshiro T, Murakami H, et al. Current status of Strongyloides infection in Okinawa, Japan. Jpn J Trop Med Hyg 1992; 20:169–173.

    Google Scholar 

  14. 14.

    Otsuzi Y. Prevalence ofStrongyloides stercolaris infection in Kagoshima, Japan and its clinical features. Report of the Study Group of Development of New Drug for Tropical Medicine in Japanese Ministry of Welfare. pp 84–89, 1991 (in Japanese).

  15. 15.

    Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection withStrongyloides stercoralis. Rev Infect Dis 1981;3:397–407.

    CAS  PubMed  Google Scholar 

  16. 16.

    Saito A.Strongyloides stercoralis. Clin Microbiol 1990;17:607–611 (in Japanese).

    Google Scholar 

  17. 17.

    Carvalho EM, Andrade TM, Andrade JA, Rocha H. Immunological features in different clinical forms of strongyloidiasis. Trans Royal Soc Trop Med Hyg 1983;77:346–349.

    Article  CAS  Google Scholar 

  18. 18.

    Genta RM, Douce RW, Walzer PD. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol 1983;23:1099–1103.

    Google Scholar 

  19. 19.

    Shikiya K, Uehara T, Uechi H, Oshira J, Arakaki T, Saito A, et al. Clinical study on ivermectin againstStrongyloides stercoralis. Jpn J Infect Dis 1991;65:1085–1090 (Engl abst).

    CAS  Google Scholar 

  20. 20.

    Shikiya K, Zaha O, Niimura S, Nakamura H, Nakayoshi C, Saito A, et al. Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis. Jpn J Infect Dis 1992;66:935–943 (Engl abst).

    CAS  Google Scholar 

  21. 21.

    Maayan S, Wormser GP, Widerhorn J, Sy ER, Kim YH, Ernst JA.Strongyloides stercolaris hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med 1987;83:945–948.

    Article  CAS  PubMed  Google Scholar 

  22. 22.

    Saito A. Acquired immunodeficiency syndrome (AIDS) and its opportunistic infection: Strongyloides stercolaris infection. Clin Microbiol 1989;16:343–347 (in Japanese).

    Google Scholar 

  23. 23.

    Miyagi J, Kinjo F, Uehara T, Kudeken N, Miyasato S, Saito A, et al. Three cases of strongyloidiasis. Clin Parasitol 1994;5:144–146 (in Japanese).

    Google Scholar 

  24. 24.

    Odayo K. Two cases of strongyloidiasis with interpreted x-ray findings. Stom Intest 1989;24:1286–1290.

    Google Scholar 

  25. 25.

    Uehara T, Kinjo F, Niimura S, Ishikawa T, Yonamine Y, Saito A. et al. Endoscopic findings of strongyloidiasis. Clin Parasitol 1994;5:142–143 (in Japanese).

    Google Scholar 

  26. 26.

    Kinjo F, Shikiya K. Strongyloidiasis. Endosc Digest 1993;5:1621–1626 (in Japanese).

    Google Scholar 

  27. 27.

    Smith B, Verghese A, Guiterrez C, Dralle W, Berk SL. Pulmonary strongyloidiasis—diagnosis by sputum gram stain. Am J Med 1985;79:663–666.

    CAS  PubMed  Google Scholar 

  28. 28.

    Saito A. Pulmonary strongyloidiasis Interaction to pulmonary tract and alveoli. Ther Res 1992;13:1231–1236 (in Japanese).

    Google Scholar 

  29. 29.

    Cook GA, Rodoriguez H, Silva H, Rodriguez-Iturbe B. Adult respiratory distress secondary to strongyloidiasis. Chest 1987;92:1115–1116.

    CAS  PubMed  Google Scholar 

  30. 30.

    Sato Y, Inoue F, Matsuyama R, Shiroma Y. Immunoblot analysis of antibodies in human strongyloidiasis. Trans Royal Soc Trop Med Hyg 1990;84:403–406.

    Article  CAS  Google Scholar 

  31. 31.

    Shiroma Y, Kiyuna S, Sato Y. Clinical studies on human strongyloidiasis in Okinawa, Japan. Jpn J Parasitol 1990;39:277–283.

    Google Scholar 

  32. 32.

    Sato Y, Toma H, Takara M, Shiroma Y. Application of enzyme-linked immunosorbent assay for mass examination of strongyloidiasis in Okinawa, Japan. Int J Parasitol 1990;20:1025–1029.

    CAS  PubMed  Google Scholar 

  33. 33.

    Arakaki T, Hasegawa H, Asato R, Ikeshiro T, Kinjo F, Saito A. A new method to detectStrongyloides stercolaris from human stool. Jpn J Trop Med Hyg 1988;16:11–17.

    Google Scholar 

  34. 34.

    Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R, Ikeshiro T. Efficacy of agar-plate culture in detection ofStrongyloides stercolaris infection. J Parasitol 1990;76:425–428.

    CAS  PubMed  Google Scholar 

  35. 35.

    Franz KH, Schneider WJ, Pohman MH. Clinical trial with thiabendazole against intestinal nematodes infecting humans. Am J Trop Med Hyg 1965;143:383–386.

    Google Scholar 

  36. 36.

    Oyakawa T, Kuniyoshi T, Arakaki T, Higashionna A, Shikiya K, Saito A, et al. New trial with thiabendazole for treatment of human strongyloidiasis. Jpn J Infect Dis 1991;65:304–310 (Engl abst).

    CAS  Google Scholar 

  37. 37.

    Shikiya K, Kuniyoshi T, Higashionna A, Arakaki T, Oyakawa T, Saito A, et al. Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole. Jpn J Infect Dis 1990;64:1408–1415 (Engl abst).

    CAS  Google Scholar 

  38. 38.

    Shikiya K, Zaha O, Niimura S, Ikema M, Nakamura H, Saito A, et al. Long term eradication rate of mebendazole therapy for strongyloidiasis. Jpn J Infect Dis 1992;66:354–359 (Engl abst).

    CAS  Google Scholar 

  39. 39.

    Shikiya K, Uechi H, Saito A, Asato R. Clinical study of mebendazole therapy for strongyloidiasis. Jpn J Med Hyg 1991;19:339–346.

    Google Scholar 

  40. 40.

    Shikiya K, Kinjo N, Ikema M, Yamashiro A, Uechi H, Saito A, et al. Comparison of efficacy on powder and mebendazole in the treatment of stercolaris. Jpn J Infect Dis 1991;65:681–686 (Engl abst).

    CAS  Google Scholar 

  41. 41.

    Shikiya K, Kuniyoshi T, Uechi K, et al. Treatment of strongyloidiasis with mebendazole long term eradication and new trials. Jpn J Infect Dis 1991;65:433–441 (Engl abst).

    CAS  Google Scholar 

  42. 42.

    Edwards G. Pharmacokinetics of antifilarial drugs. Trop Med Parasitol 1987;38:64.

    Google Scholar 

  43. 43.

    Freedman DO, Zierdt WS, Lujan A, Nutman TB. The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in human. J Infect Dis 1989;159:1151.

    CAS  PubMed  Google Scholar 

  44. 44.

    Shikiya K, Zaha O, Niimura S, Nakamura H, Nakayoshi C, Saito A, et al. Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis. Jpn J Infect Dis 1990;66:935–943 (Engl abst).

    Google Scholar 

  45. 45.

    Ette EI, Thomas WO, Achumba JI. Ivermectin: a longacting microfilaricidal agent. DIPC Ann Pharmacother 1990;24:426.

    CAS  Google Scholar 

  46. 46.

    Pacoue M, Munoz B, Greene BM, White AT, Dukuly Z, Taylor HR. Safety of and compliance with communitybased ivermectin therapy. Lancet 1990;335:1377.

    Google Scholar 

  47. 47.

    DeSole GD, Dadzie KW, Giese J, Remme J. Lack of adverse reactions in ivermectin treatment of onchocerciasis. Lancet 1990;335:1106.

    Article  CAS  Google Scholar 

  48. 48.

    Rothova A, Van der Lelij A, Stilma JS, Wilson WR, Barbe RF. Side effects of ivermectin in treatment of onchocerciasis. Lancet 1989;i:1439.

    Google Scholar 

  49. 49.

    Lariviere M, Vingtain P, Aziz M, Beauvalis B, Weimann D, Cerouin F, et al. Double blind study of ivermectin and diethylcarbamazine on African onchocercids in patients with ocular involvement. Lancet 1990;i:174.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Atsushi Saito MD, PhD.

About this article

Cite this article

Saito, A. Strongyloidiasis: Epidemiology, clinical manifestations and new methods for diagnosis and treatment. J Infect Chemother 1, 98–106 (1995). https://doi.org/10.1007/BF02348752

Download citation

Key words

  • strongyloidiasis
  • Strongyloides stercoralis
  • culture method
  • ivermectin